LUN88-3
Phase III Study of VP-16 + Cisplatin Alone (VP) + Ifosfamide (VIP) for Previously Untreated Extensive Small Cell Lung Cancer
Phase III Study of VP-16 + Cisplatin Alone (VP) + Ifosfamide (VIP) for Previously Untreated Extensive Small Cell Lung Cancer
© 2024 Hoosier Cancer Research Network | 7676 Interactive Way, Suite 120 · Indianapolis, IN 46278 | (317) 921-2050 | contact@hoosiercancer.org | Terms of Use | Privacy Policy | Sitemap
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter